Solara Active Pharma Sciences Ltd offers a Right Issue valued at Rs 449.95 Crores. The subscription for this Right Issue will be open from May 28, 2024, to June 11, 2024. For every fully paid-up equity share held on the record date of May 15, 2024, shareholders are entitled to ₹1 Rights issue Share. The face value of each share is Rs. 10, with the Right Issue price set at Rs. 375 per share.
Corporate Action | |
---|---|
Security Name | Solara Active Pharma Sciences Ltd |
Issue Open/Close | May 28, 2024-June 11, 2024 |
Record Date | May 15, 2024 |
Issue Size (Amount) | ₹449.95 Crores |
Issue Size (Shares) | ₹11,998,755 |
Right Issue Price | ₹375 per share |
Face Value | ₹10 Per Shares |
CMP | ₹455 |
Renunciation of Rights Entitlements | June 5, 2024 |
Terms of Payment | Issue Price of 375/- per share is payable as 131.25 per share on Application. The remaining amount of 243.75 will be called within 24 months from the date of allotment in the Issue |
Entitlement | ₹1 Rights Equity Shares for every 3 fully paid-up Equity Shares held on Record Date |
Disclaimer: The Information compiled by CEBPL on a best-efforts basis from information CEBPL received from third-party vendors, is believed to be reliable. The information may contain errors or omissions and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantees the performance of the intermediary or provides any assurance of returns to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com